5.3 Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin Patients receiving BYDUREON BCISE in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1) and Drug Interactions (7)]
The decision regarding tirzepatide management should be made collaboratively between the surgical team, anesthesiologist, and prescribing physician
DSIP has stress-protective and adaptogen activity, normalizing brain metabolism in cases of drug addiction (amphetamine), stress, and stroke [6, 7, 8]
It enhances the production of collagen peptides
After your appointment, youll receive a summary that you can submit to your private insurance provider for possible reimbursement
Clemens, S